The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Celgene
Honoraria - Gilead Sciences; Janssen; RIEMSER; Takeda
Consulting or Advisory Role - RIEMSER
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; RIEMSER; Takeda

Comparison of clinical scoring systems in aggressive B-cell lymphomas (BCL): An individual patient-level analysis across international trials (SEAL).
 
Amy S. Ruppert
No Relationships to Disclose
 
Jesse G. Dixon
No Relationships to Disclose
 
Gilles A. Salles
Honoraria - Abbvie; Amgen; Celgene; Gilead Sciences; Janssen; Merck; MorphoSys; Novartis; Roche/Genentech; SERVIER; Takeda
Consulting or Advisory Role - Acerta Pharma; Celgene; Epizyme; Gilead Sciences; Janssen; Kite, a Gilead company; Merck; morphosys; Novartis; Pfizer; Roche/Genentech; SERVIER
 
Anna K. M. Wall
No Relationships to Disclose
 
David Cunningham
Research Funding - 4SC (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Merrimack (Inst); Sanofi (Inst)
 
Viola Poeschel
Speakers' Bureau - Hexal
Travel, Accommodations, Expenses - Abbvie; Amgen; Roche
 
Corinne Haioun
Honoraria - Amgen; Gilead Sciences; Novartis; Servier/Pfizer
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen-Cilag; Roche; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Roche
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; SERVIER
Consulting or Advisory Role - Janssen; Karyopharm Therapeutics; Roche
Travel, Accommodations, Expenses - Roche
 
Herve Ghesquieres
Consulting or Advisory Role - Celgene; Gilead Sciences
Travel, Accommodations, Expenses - Amgen; Gilead Sciences; Roche
 
Marita Ziepert
No Relationships to Disclose
 
Jocelyne Flament
Employment - Celgene
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Celgene; Denovo Biopharma; Gilead Sciences; Karyopharm Therapeutics; OptumRx; Pharmacyclics/Janssen; Seagen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Qian Shi
No Relationships to Disclose
 
Norbert Shmitz
No Relationships to Disclose